U.S. mRNA Synthesis Raw Materials Market to Soar to USD 2.59 Billion by 2035; Strategic Supply Chain Investments Accelerate Growth

Healthcare, Press Release

The U.S. mRNA Synthesis Raw Materials Market is on track for remarkable expansion, projected to grow from an estimated USD 777.98 million in 2026 to USD 2,588.71 million by 2035, representing a CAGR of 14.26% over the forecast period. This surge is driven by escalating adoption of mRNA technology in vaccines and therapeutics development, rising […]